A study of Quadrivalent influenza vaccine
Phase of Trial: Phase III
Latest Information Update: 08 Nov 2018
At a glance
- Drugs Influenza-virus-vaccine-quadrivalent-Sinovac-Biotech (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Sinovac Biotech
- 08 Nov 2018 According to a Sinovac Biotech media release, the company expects to complete this study by 2018.
- 11 May 2018 According to a Sinovac Biotech media release, this trial was initiated in the fourth quarter of 2017.
- 11 May 2018 Status changed from planning to recruiting, as reported in a Sinovac Biotech media release.